Jeuveau
Chemical Name | prabotulinumtoxinA-xvfs |
Dosage Form | Injectable (intramuscular; 100 units/vial) |
Drug Class | Inhibitors |
System | Musculoskeletal |
Company | Evolus |
Approval Year | 2019 |
Indication
- Jeuveau is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.